Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Cancer Renal Cell Cancer (RCC) Pancreatic Cancer Solid Tumors Skin Cancer Malignant Melanoma Renal Cell Carcinoma Sarcoma Non Hodgkin Lymphoma (NHL) Lymphoma Colorectal Cancer (CRC) Lung Cancer Non Small Cell Lung Carcinoma Ovarian Cancer Breast Cancer Thyroid Cancer Melanoma Head and Neck Cancer Head and Neck Neoplasms
For the latest version of this information please go to www.forpatients.roche.com